NNE is providing a conceptual design for refurbishment of a facility. This will support the transition from research to early clinical manufacturing of allogenic gene-edited cell therapies targeted towards chronic disease - in the customer’s own portfolio.
Our conceptual design provided the customer with basis for design and basis for decision. We brought in outside perspectives on cost estimate, facility concept and gene editing technology in general to strengthen the overall CD.
The co-creation workshop format NNE used was very engaging, practical and visual. It was clear to everybody what the intention and desired outcome was - including benchmarking with our defined business drivers.”
Fact box
Customer
Confidential
Country
USA
Technology
Gene-edited cell therapies
Format
- Co-creation with customer + contractor
- Workshop format
- Test of solution alternatives
Duration
Focused 2 week workshop
Total of 8 weeks
Project completion
2019-ongoing
Size
4,000 m2
Services provided
Conceptual design
